NIH-funded research R01 grant

Investigating brain changes in multiple system atrophy

Official title: Single Cell Transcriptomic Profiling of Multiple System Atrophy Brain

Funded at New York University School of Medicine · NIH-10801665 · Data updated 2026-11-12

This study is looking at brain tissue from people with multiple system atrophy (MSA) to learn more about how the disease affects different brain cells, especially those that support nerve health, which could help us find new ways to treat MSA in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2024
Project endJuly 31, 2028
Funding year2024
Award (this year)$666,123
NIH project number1R01NS131658-01A1
Project IDNIH-10801665 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with multiple system atrophy, particularly those with either MSA-P or MSA-C subtypes.

Less likely to help

Patients with other neurodegenerative diseases or those not diagnosed with multiple system atrophy may not benefit from this research.

What this research studies

This research focuses on understanding multiple system atrophy (MSA), a rare neurodegenerative disease, by analyzing brain tissue from affected patients. Using advanced techniques like single nucleus RNA sequencing, the study aims to identify specific changes in different types of brain cells, particularly oligodendrocytes, which are crucial for neuronal health. By examining tissue from various brain regions, the research seeks to uncover the mechanisms behind the disease and how it affects brain function. This could lead to better insights into the progression of MSA and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with multiple system atrophy.

How similar studies have gone: While research on neurodegenerative diseases is ongoing, this specific approach using single nucleus RNA sequencing in MSA is relatively novel and has not been extensively tested.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Kang, Un Jung — New York University School of Medicine
  • Study coordinator: Kang, Un Jung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.